Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04889911 · ClinicalTrials.gov registry record · NA
Pilot RCT of Self-stigma Treatment for First Episode Psychosis
A NA study of First Episode Psychosis and Youth, sponsored by John Jay College of Criminal Justice, City University of New York.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT04889911 is a NA study of First Episode Psychosis and Youth that is actively recruiting participants, run by John Jay College of Criminal Justice, City University of New York. The registered enrollment target is 40 participants, below the 6,428-participant average among 8 other First Episode Psychosis trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04889911, a NA study of First Episode Psychosis and Youth, is actively recruiting participants, sponsored by John Jay College of Criminal Justice, City University of New York.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall purpose of the proposed exploratory intervention development application, is to conduct research that will inform the adaptation and preliminary testing of NECT modified for youth (aged 15-24) with first episode psychosis (FEP), targeting self-concept and illness conceptions to increase treatment engagement. The specific aims of the project are to: 1) adapt NECT to be responsive to the needs and preferences of youth with FEP, and 2) Assess the feasibility, acceptability and preliminary effectiveness of the modified intervention (NECT-YA) combined with coordinated specialty care (CSC) services, compared to CSC services alone, in a small (n = 40) RCT.
Conditions Studied
Interventions
- BEHAVIORAL Narrative Enhancement and Cognitive Therapy- Young Adult, Combined with Coordinated Specialty Care
- OTHER Coordinated Specialty Care
Study Locations (1)
Indiana
- Eskenazi Health, PARC Program - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-08-01 |
| Est. Completion | 2025-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04889911
The ClinicalTrials.gov registry entry for NCT04889911 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,428-participant average among 8 other First Episode Psychosis trials with a reported enrollment target (99% lower). The listed sponsor is John Jay College of Criminal Justice, City University of New York, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with First Episode Psychosis appearing as the primary indexed condition, and to 2 interventions - of which Narrative Enhancement and Cognitive Therapy- Young Adult, Combined with Coordinated Specialty Care is the first listed.
NCT04889911 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT04889911 about?
NCT04889911 is a clinical study titled "Pilot RCT of Self-stigma Treatment for First Episode Psychosis". The overall purpose of the proposed exploratory intervention development application, is to conduct research that will inform the adaptation and preliminary testing of NECT modified for youth (aged 15-24) with first episode psychosis (FEP), targeting self-concept and illness conceptions to increase ...
What is the current status of trial NCT04889911?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-08-01. Estimated completion is 2025-08.
What conditions does trial NCT04889911 study?
This clinical trial studies the following conditions: First Episode Psychosis, Youth.
What interventions are being tested in trial NCT04889911?
The interventions under investigation include: Narrative Enhancement and Cognitive Therapy- Young Adult, Combined with Coordinated Specialty Care (BEHAVIORAL), Coordinated Specialty Care (OTHER).
Who is sponsoring clinical trial NCT04889911?
This trial is sponsored by John Jay College of Criminal Justice, City University of New York, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04889911 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for First Episode Psychosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Digital Strategies to Advance Help-Seeking - Aim 3
RECRUITING · NA
-
Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis
RECRUITING · NA
-
Optimizing Engagement in Services for First-Episode Psychosis
ACTIVE NOT RECRUITING · NA
-
Digital Strategies to Advance Help-Seeking Aim 1 and 2
RECRUITING
-
Early-Phase Schizophrenia: Practice-based Research to Improve Outcomes
RECRUITING
-
Disengagement in CSC: Identifying Those at Risk and Addressing Their Needs
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.